CASSANDRA AYRE: Open Payments
NPI 1861123168 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,686 in 168 payments from 19 companies in 2025. Trend: 2023 $4,998 · 2024 $4,372 · 2025 $3,686
Food & beverage: $3,522Education: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $823 |
| Janssen Biotech, Inc. | 23 | $434 |
| Incyte Corporation | 16 | $417 |
| Novartis Pharmaceuticals Corporation | 15 | $277 |
| Amgen Inc. | 8 | $256 |
| Regeneron Healthcare Solutions, Inc. | 10 | $238 |
| Organon LLC | 12 | $237 |
| GENZYME CORPORATION | 6 | $231 |
| Lilly USA, LLC | 7 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $106 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, OPZELURA, RINVOQ, Otezla, COSENTYX, TALTZ.
Industry payments across MA — which companies pay providers there.
